Translating gut microbiome research into therapies for type 1 diabetes
An overview of existing knowledge on the gut microbial metabolic pathways and microbiota‐derived metabolites that are dysregulated or altered in T1D is provided and recent advances in gut microbiome‐based therapies, ranging from prebiotics to faecal microbiota transplantation (FMT), are addressed in both preclinical an...